GLP-1 signaling has been shown to counteract key pathological processes such as oxidative stress, neuronal apoptosis, mitochondrial dysfunction, and neuroinflammation—all central contributors to conditions like AD, PD, stroke and depression. The gene discussed is GCG; the disease is depressive symptom measurement.